Massachusetts General Hospital:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Massachusetts General Hospital - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7271
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Massachusetts General Hospital (MGH) is a healthcare service provider which offers research, education and therapeutic care services. The hospital provides treatment and patient care services in the therapeutic areas of allergy and immunology; hematology, orthopaedics, neurology and neurosurgery, oncology, dermatology, gastroenterology, cardiology, infectious diseases, pulmonary, urology, among others. It also offers palliative care, pediatrics and pediatric surgery; pelvic floor disorders center, physical medicine and rehabilitation service; plastic and reconstructive surgery, primary care, primary care associates, psychiatry, pulmonary and critical care medicine, radiation oncology and radiology services, among others. MGH also provides research, education and training programs at different research centers include ALS multidisciplinary clinic, back bay healthcare center, beacon hill primary care, blood donor center, Blum center, primary care-revere, burns center, cancer center for cardiac surgery, cardiology and other services and others.MGH is headquartered in Boston, Massachusetts, the US.

Massachusetts General Hospital – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Massachusetts General Hospital, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Massachusetts General Hospital, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Massachusetts General Hospital, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Massachusetts General Hospital, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Massachusetts General Hospital, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Massachusetts General Hospital, Medical Equipment, Deal Details 11
Partnerships 11
PAVmed Enters into Licensing Agreement with Tufts University, Massachusetts Eye and Ear Infirmary and Massachusetts General Hospital 11
Heidelberg Engineering Enters into Licensing Agreement with Massachusetts General Hospital 13
MolecularMD Enters Into Licensing Agreement For LKB1, Cancer Diagnosis Technology 14
INOVA Diagnostics Enters Into Licensing Agreement With AmberGen And Massachusetts General Hospital For Two Autoantigen Biomarkers 16
Protea Biosciences Enters into Agreement with Massachusetts General Hospital 17
MyndYou Enters into Research Partnership with Massachusetts General Hospital 18
Infraredx Enters into R&D Agreement with Massachusetts General Hospital 19
EKF Diagnostics Enters into Research Agreement with Massachusetts General Hospital 20
Canon Enters Into Co-Development Agreement With Massachusetts General Hospital And Brigham and Women’s Hospital 21
Perkinelmer Enters Into Co-Development Agreement With Massachusetts General Hospital 22
Affymetrix Enters Into Co-Development Agreement With Massachusetts General Hospital For New Oncology Biomarker Tests 23
Massachusetts General Hospital – Key Competitors 24
Massachusetts General Hospital – Key Employees 25
Massachusetts General Hospital – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Joint Venture 26
Recent Developments 27
Legal and Regulatory 27
Apr 09, 2018: Patent Infringement Suits Filed Today Against 18 Manufacturers and Distributors of Fractional RF Microneedle Systems 27
Government and Public Interest 28
Jul 30, 2018: Nano-optic endoscope sees deep into tissue at high resolution 28
Mar 22, 2018: Study supports biomarker assay for emergency department diagnosis of acute heart failure 30
Jul 20, 2017: fMRI, EEG may Provide Early Detection of Consciousness in Patients with Severe Traumatic Brain Injury 32
Apr 06, 2017: Urine test may be able to diagnose obstructive sleep apnea in children with Down Syndrome 34
Product News 35
Jun 18, 2018: Faster analysis of medical images 35
May 07, 2018: Artificial intelligence detects patterns of gut microbes that indicate cholera risk 37
May 02, 2018: Artificial intelligence better than most human experts at detecting cause of preemie blindness 39
Apr 24, 2018: Imaging may allow safe tPA treatment of patients with unwitnessed strokes 41
Mar 23, 2018: Artificial intelligence scanner could improve medical imaging 43
Feb 27, 2018: Microfluidic device captures, allows analysis of tumor-specific extracellular vesicles 44
Feb 16, 2018: Expanding hepatitis C testing to all adults is cost-effective and improves outcomes 46
Aug 06, 2017: New AI algorithm Monitors Sleep with Radio Waves 48
Jun 12, 2017: Cardiac CT angiography appears better at predicting future risk for patients with chest pain 50
Apr 12, 2017: WorldCare Clinical Commences Medical Device Study using Advanced Cardiac Imaging 51
Other Significant Developments 52
Feb 07, 2018: AHRA and Canon Medical Systems Announce 2017 Putting Patients First Grant Winners 52
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53

List of Tables
Massachusetts General Hospital, Medical Equipment, Key Facts 2
Massachusetts General Hospital, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Massachusetts General Hospital, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Massachusetts General Hospital, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Massachusetts General Hospital, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Massachusetts General Hospital, Deals By Market, 2012 to YTD 2018 9
Massachusetts General Hospital, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
PAVmed Enters into Licensing Agreement with Tufts University, Massachusetts Eye and Ear Infirmary and Massachusetts General Hospital 11
Heidelberg Engineering Enters into Licensing Agreement with Massachusetts General Hospital 13
MolecularMD Enters Into Licensing Agreement For LKB1, Cancer Diagnosis Technology 14
INOVA Diagnostics Enters Into Licensing Agreement With AmberGen And Massachusetts General Hospital For Two Autoantigen Biomarkers 16
Protea Biosciences Enters into Agreement with Massachusetts General Hospital 17
MyndYou Enters into Research Partnership with Massachusetts General Hospital 18
Infraredx Enters into R&D Agreement with Massachusetts General Hospital 19
EKF Diagnostics Enters into Research Agreement with Massachusetts General Hospital 20
Canon Enters Into Co-Development Agreement With Massachusetts General Hospital And Brigham and Women’s Hospital 21
Perkinelmer Enters Into Co-Development Agreement With Massachusetts General Hospital 22
Affymetrix Enters Into Co-Development Agreement With Massachusetts General Hospital For New Oncology Biomarker Tests 23
Massachusetts General Hospital, Key Competitors 24
Massachusetts General Hospital, Key Employees 25
Massachusetts General Hospital, Joint Venture 26

List of Figures
Massachusetts General Hospital, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Massachusetts General Hospital, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Massachusetts General Hospital, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Massachusetts General Hospital, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Massachusetts General Hospital, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Massachusetts General Hospital, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Massachusetts General Hospital, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Massachusetts General Hospital, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Massachusetts General Hospital:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IMCD N.V.:企業のM&A・事業提携・投資動向
    IMCD N.V. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's IMCD N.V. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • HD Supply Holdings, Inc.:企業の戦略・SWOT・財務情報
    HD Supply Holdings, Inc. - Strategy, SWOT and Corporate Finance Report Summary HD Supply Holdings, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Mitsui Fudosan Co Ltd (8801):企業の財務・戦略的SWOT分析
    Mitsui Fudosan Co Ltd (8801) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Centrica Plc (CNA):企業の財務・戦略的SWOT分析
    Centrica Plc (CNA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Alexander & Baldwin Inc (ALEX):企業の財務・戦略的SWOT分析
    Alexander & Baldwin Inc (ALEX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Mudman Public Company Limited (MM):企業の財務・戦略的SWOT分析
    Mudman Public Company Limited (MM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • MonTa Biosciences ApS:製薬・医療:M&Aディール及び事業提携情報
    Summary MonTa Biosciences ApS (MonTa Biosciences) is a biotechnology company that develops and commercializes immuno-oncology therapeutics for cancer therapy. Its pipeline products include MBS2, and MBS5 used for the treatment of cancer and infectious diseases. The company’s technology is based on T …
  • Applied Medical Resources Corporation:企業の戦略的SWOT分析
    Applied Medical Resources Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Northland Power Inc (NPI):電力:M&Aディール及び事業提携情報
    Summary Northland Power Inc. (Northland Power) is an independent power producer that develops, finances, builds, owns, and operates clean and green power projects in Canada and internationally. The company generates energy from natural gas, biomass, landfill gas, wind and solar sources. In thermal g …
  • Gujarat State Petroleum Corp Ltd:企業の戦略的SWOT分析
    Gujarat State Petroleum Corp Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Bonheur ASA (BON):石油・ガス:M&Aディール及び事業提携情報
    Summary Bonheur ASA (Bonheur) is an oil and gas investment service provider that offers investment services for various energy sectors. The company invests in renewable energy, cruise, shipping and offshore wind, offshore drilling, and other investments. It operates shipping vessels for transport an …
  • Optus Inc:企業の戦略的SWOT分析
    Optus Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • West Cornwall Pasty Co. Ltd:企業の戦略・SWOT・財務分析
    West Cornwall Pasty Co. Ltd - Strategy, SWOT and Corporate Finance Report Summary West Cornwall Pasty Co. Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Usha Martin Limited:企業の戦略・SWOT・財務情報
    Usha Martin Limited - Strategy, SWOT and Corporate Finance Report Summary Usha Martin Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Icelandair Group:戦略・SWOT・企業財務分析
    Icelandair Group - Strategy, SWOT and Corporate Finance Report Summary Icelandair Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Laerdal Medical AS:企業の戦略的SWOT分析
    Laerdal Medical AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Biovista Inc-製薬・医療分野:企業M&A・提携分析
    Summary Biovista Inc (Biovista) is a drug development company that provides COSS platform technology support in uncovering non-obvious correlations between drugs. The company’s products are used for the treatment of neurodegenerative diseases, epilepsy, oncology and orphan diseases. It offers servic …
  • SAS Group:戦略・SWOT・企業財務分析
    SAS Group - Strategy, SWOT and Corporate Finance Report Summary SAS Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • CMP Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CMP Pharma Inc (CMP Pharma), formerly Carolina Medical Products Company Inc is a specialty pharmaceutical company that develops and manufactures generic prescription, non-prescription and skin care products. The company’s prescription products include SPS suspension, isoniazid oral solution …
  • Central and North West London NHS Foundation Trust:企業の戦略的SWOT分析
    Central and North West London NHS Foundation Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key compet …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆